Evidence map›Paper›PMID 34501257›Full record

ArticleJournal of clinical medicine2021

Oocyte Vitrification for Fertility Preservation in Women with Benign Gynecologic Disease: French Clinical Practice Guidelines Developed by a Modified Delphi Consensus Process.

Blandine Courbiere, Enora Le Roux, Emmanuelle Mathieu d'Argent, Antoine Torre, Catherine Patrat, Christophe Poncelet, Jacques Montagut, Anne-Sophie Gremeau, Hélène Creux, Maëliss Peigné and 6 more

Open access · goldAbstract read
In one paragraph

Article in Journal of clinical medicine, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.7field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 12 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Review
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 7 institutions in 1 country.

Blandine CourbiereDepartment of Gynecology-Obstetric and Reproductive Medicine, AP-HM, Hôpital La Conception, 13005 Marseille, France.ORCID 0000-0002-1847-4509
Enora Le RouxUnité d'Epidémiologie Clinique, Hôpital Universitaire Robert Debré, AP-HP Nord-Université de Paris, Inserm, CIC 1426, 75019 Paris, France.
Emmanuelle Mathieu d'ArgentDepartment of Gynecology-Obstetric and Reproductive Medicine, GRC6-UPMC, Centre Expert en Endométriose (C3E), Université Pierre-et-Marie-Curie Paris 6, Hôpital Tenon, CHU de Tenon, AP-HP, 4, rue de la Chine, 75020 Paris, France.
Antoine TorreDepartment of Gynecology-Obstetric and Reproductive Medicine, CHU Rouen, 37 bd Gambetta, 76000 Rouen, France.ORCID 0000-0001-6515-6928
Catherine PatratService de Biologie de la Reproduction-CECOS, APHP Centre-Université de Paris, Site Cochin, Inserm U1016, 75014 Paris, France.
Christophe PonceletDepartment of Gynecology-Obstetric, UFR SMBH Leonard de Vinci, CH René Dubos, 95000 Cergy-Pontoise, France.
Jacques MontagutInstitut Francophone de Recherche et d'Etudes Appliquées à la Reproduction, Ifreares Toulouse, 31000 Toulouse, France.
Anne-Sophie GremeauDepartment of Gynecologic Surgery and IVF, Clermont-Ferrand, University Hospital Clermont-Ferrand, 63000 Clermont-Ferrand, France.
Hélène CreuxClinique Saint Roch, Department of Gynecology-Obstetric and Reproductive Medicine, 34000 Montpellier, France.
Maëliss PeignéUniversité Sorbonne Paris Nord-Paris 13, 93200 Saint-Denis, France.
Isabella Chanavaz-LacherayCentre d'Endométriose, Clinique Tivoli Ducos, 33000 Bordeaux, France.
Lara DirianEndoFrance, Association Française de lutte contre l'Endométriose, 70190 Tresilley, France.
Xavier FritelDepartment of Gynecology-Obstetric and Reproductive Medicine, CHU Poitiers, 86000 Poitiers, France.ORCID 0000-0002-4987-8127
Jean-Luc PoulyDepartment of Gynecology-Obstetric, CH Moulins Yzeure, 03000 Moulins, France.
Arnaud FauconnierDepartment of Gynecology and Obstetrics, CHI Poissy-Saint-Germain-en Laye, 78300 Poissy, France.
On Behalf Of The PreFerBe Expert Panel
Inserm · FRSorbonne Université · FRCentre Hospitalier Universitaire de Clermont-Ferrand · FRCentre Hospitalier Universitaire de Rouen · FRCentre National de la Recherche Scientifique · FRHôpital Saint Roch · FRUniversité Paris-Saclay · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

International guidelines are published to provide standardized information and fertility preservation (FP) care for adults and children. The purpose of the study was to conduct a modified Delphi process for generating FP guidelines for BGD. A steering committee identified 42 potential FP practices for BGD. Then 114 key stakeholders were asked to participate in a modified Delphi process via two online survey rounds and a final meeting. Consensus was reached for 28 items. Among them, stakeholders rated age-specific information concerning the risk of diminished ovarian reserve after surgery as important but rejected proposals setting various upper and lower age limits for FP. All women should be informed about the benefit/risk balance of oocyte vitrification-in particular about the likelihood of live birth according to age. FP should not be offered in rASRM stages I and II endometriosis without endometriomas. These guidelines could be useful for gynecologists to identify situations at risk of infertility and to better inform women with BGDs who might need personalized counseling for FP.

Indexed as

benign gynecologic diseaseconsensus studyfertility preservationmodified Delphi methodoocyte vitrification

Identifiers

PMID34501257
PMCPMC8432013
OpenAlexW3180791917

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.